Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IGV vs GSK✓SelectedUSD · GSKIGV vs GSK performance historyLatest closeAs of-4.62%11/20
Stock and ETF performance explorer

IGV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.4%
GSK return
+40.7%
Excess return
-33.3%
Maximum drawdown
-43.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.6%-0.1%-4.5%-4.6%
7D-9.4%-5.3%-4.1%-9.0%
30D-15.8%-3.7%-12.1%-15.5%
3M-10.1%-7.3%-2.8%-9.5%
6M-1.8%-4.2%+2.5%-1.6%
YTD-13.3%+0.9%-14.1%-14.3%
1Y-9.1%+7.3%-16.3%-11.0%
3Y+20.7%+52.7%-32.0%+8.2%
All+7.4%+40.7%-33.3%-12.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling